GALD

Galderma Group N

GALD • SW

Fr178.55+Fr2.55 (1.45%)

Estimate

P/E

60.3

EPS

2.96

Beta

-0.097

Growth

Revenue, YoY

405.74%

Net income, YoY

1,218.61%

FCF, YoY

1,635.86%

Forecast

P/E (FWD)

26.7

EPS (FWD)

6.69

Dividends

Dividend yield

0.2%

Annual payout

Fr0.35

Next ex. div date

April 24, 27

Payout

12.04%

Dividend growth streak

1 year

Div.rating

About the company

Ticker

GALD

ISIN

CH1335392721

Country

Other

Sector (GICS)

Other

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.

Frequently asked questions

What sector does Galderma Group N (GALD) operate in?

Galderma Group N belongs to the Other sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Galderma Group N (GALD) current stock price?

As of the latest data, Galderma Group N stock price is CHF 178.55, with a previous close of CHF 176.00. Galderma Group N gained CHF 2.55 in the last trading session, representing a 1.45% increase.

What is Galderma Group N (GALD) current market capitalization?

Galderma Group N market cap is approximately 41.64 billion.

What is Galderma Group N (GALD) Earnings Per Share (EPS)?

The trailing EPS is CHF 2.96, and the forward EPS is CHF 6.69.

What is Galderma Group N (GALD) Price-to-Earnings (P/E) ratio?

Galderma Group N current P/E ratio is 60.32, with a forward P/E of 26.69.

What is Galderma Group N (GALD) EBITDA?

Galderma Group N EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 772.71 million.

Does Galderma Group N (GALD) pay dividends?

Yes. Galderma Group N pays annual dividends with an annualized yield of 0.2% and an estimated annual payout of CHF 0.35 per share.

When is the next ex-dividend date for Galderma Group N (GALD)?

The next ex-dividend date is scheduled for April 24, 2027.

When is Galderma Group N (GALD) next earnings report?

Galderma Group N is expected to release its next earnings report on March 31, 2026.

What is Galderma Group N (GALD) beta (volatility) score?

Galderma Group N has a beta of -0.097, indicating lower volatility than the overall market.